Ortho Clinical Diagnostics Holdings plc Return on Equity

Ortho Clinical Diagnostics Holdings plc (OCDX) currently reports a ROE of -0.09%. That is above the Healthcare sector average of -75.84%. Use the charts on this page to explore Ortho Clinical Diagnostics Holdings plc's ROE history and peer comparisons.

Ortho Clinical Diagnostics Holdings plc's ROE of -0.09% is higher than the Healthcare sector average of -75.84%. That is roughly 99.9% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Ortho Clinical Diagnostics Holdings plc's current -0.09% should be judged against Healthcare norms (sector average: -75.84%) and against OCDX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -0.09%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -75.84%. From there, open related valuation or income-statement pages for Ortho Clinical Diagnostics Holdings plc, and consider following OCDX for alerts when major investors trade the stock.

Ortho Clinical Diagnostics Holdings plc is classified in the Healthcare sector. On ROE, it currently shows -0.09% versus a sector average near -75.84%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OCDX with unrelated industries.